The activities of the Fourth International Emirates Conference on Combating Counterfeiting in Medical Products, organized by the Ministry of Health and Community Protection, kicked off today at the Expo 2020 Dubai Exhibition Center. Fraudulent to protect the health of communities from drug fraud.
The conference, which concludes tomorrow, will be attended by 10 international organizations and Western, Arab and Gulf bodies concerned with combating drug fraud, including the United Nations, the World Health Organization, organizations specialized in the drug industry and combating drug counterfeiting, and experts from different countries of the world. The participants in the conference will discuss the growing phenomenon of manufacturing counterfeit medicines and selling them through websites all over the world.
Specialists from the US Food and Drug Administration, the British Medicines Authority, the European Medicines Authority, the United Nations, the World Customs Organization and the Council of Europe to combat cybercrime spoke at the conference.
The Ministry’s Assistant Undersecretary for the Health Regulation Sector and Conference Chair, Dr. Amin Hussein Al-Amiri, stressed that the UAE government pays special attention to the pharmaceutical sector, and there is great interest from the competent authorities in the various health institutions in the country. He pointed out that the UAE is among the best countries in the region in combating drug fraud in coordination and cooperation with relevant international and global organizations, led by the World Health Organization, the United Nations, the World Customs Union and the US Food and Drug Authority.
He pointed out that according to the statistics of the World Health Organization, 1% of medicines in the developed world are counterfeit, while the percentage reaches 10% in some African and East Asian countries, while the percentage of fraudulent and counterfeit medicines reaches 33% of the volume of medicines in some developing countries.
He pointed out that 50% of the medicines sold online are counterfeit, explaining that counterfeiting operations target medicines of high value, or those with a high consumption rate, and popular and sought-after medicines.
Al Amiri continued: “The Ministry of Health and Community Protection is focusing with the health authorities in the country, in continuous cooperation and coordination with the Federal Customs Authority and local customs departments, on combating drug fraud, through electronic programs and smart electronic applications concerned with this, with the use of modern technologies to distinguish between the original drug and the fake and counterfeit drug during A few minutes, which enhances the UAE’s global position in attracting innovative and similar medicines and their rapid registration, while supporting the import and re-export programs that characterize the country.”
The Ministry’s Assistant Undersecretary for the Health Regulation Sector pointed out that international companies take the UAE as their global and regional headquarters, with the total number of scientific offices reaching 91 offices representing international drug companies, in addition to launching their logistical services from the UAE, through which 41 countries in the world are supported. Medicines and medical supplies. He pointed out that the UAE’s distinction in combating counterfeit and counterfeit medicine constitutes a protection for society, and a protection for countries that are supplied with medicines through the Emirates.
Al-Amiri indicated that the Ministry of Health and Community Protection issues hundreds of circulars and warnings annually about falsified medicines and medical preparations, which are monitored through the Supreme National Committee for Pharmacovigilance headed by the Ministry with all health authorities with jurisdiction at the state level, and the Ministry of Health is directly linked to the Uppsala Center for Drug Monitoring. The Ministry of Health monitors websites that market some types of medicines, pointing out that the UAE bears its responsibility towards the world in combating drug fraud.
For his part, Director of Regulation and Rehabilitation at the World Health Organization Rogerio Jasper said: “The value of counterfeit medicines in low-income countries is estimated at about $30.5 billion, while countries that have achieved advanced efficiency and continuous self-development have achieved 28% for the year 2020.” He pointed out that the organization launched in 2013 the drug control and audit program, to improve the quantity, quality and quality of data related to counterfeit and low-quality medicines, and analyze this data with the aim of prevention, monitoring and taking the necessary measures to protect public health.
He added that the organization has a global database of substandard and falsified medicines, according to reports it receives from regulatory authorities in member states, which aims to provide technical and practical support to protect society, and analyze this data. The Medicinal Product Trace Program aims to prevent counterfeit medicines from entering regulated supply baskets, to improve drug safety and protect patients.
Dr. Magdy Abdo, Regional Director of Health Legislation and Drug Registration for Servier, said: “The conference is of great importance as it discusses addressing the manufacture of counterfeit medicine, smuggling it to global markets, and selling it through websites, social media platforms and smart phone applications. Today, participants in the conference are discussing how to protect patients. From counterfeit and fraudulent medicine as it threatens to cause serious complications to patients.”
He pointed out that the sessions are discussing the classification of fraudulent medicine as an organized crime, as it deliberately targets a segment of patients, and is considered the first crime against patients in low-income countries. He pointed out that counterfeit pharmaceutical products cause a loss of confidence in medicines produced by licensed companies, in health care service providers, and in health systems.
The activities of the Fourth International Emirates Conference on Combating Counterfeiting in Medical Products, organized by the Ministry of Health and Community Protection, kicked off today at the Expo 2020 Dubai Exhibition Center. Fraudulent to protect the health of communities from drug fraud.
The conference, which concludes tomorrow, will be attended by 10 international organizations and Western, Arab and Gulf bodies concerned with combating drug fraud, including the United Nations, the World Health Organization, organizations specialized in the drug industry and combating drug counterfeiting, and experts from different countries of the world. The participants in the conference will discuss the growing phenomenon of manufacturing counterfeit medicines and selling them through websites all over the world.
Specialists from the US Food and Drug Administration, the British Medicines Authority, the European Medicines Authority, the United Nations, the World Customs Organization and the Council of Europe to combat cybercrime spoke at the conference.
The Ministry’s Assistant Undersecretary for the Health Regulation Sector and Conference Chair, Dr. Amin Hussein Al-Amiri, stressed that the UAE government pays special attention to the pharmaceutical sector, and there is great interest from the competent authorities in the various health institutions in the country. He pointed out that the UAE is among the best countries in the region in combating drug fraud in coordination and cooperation with relevant international and global organizations, led by the World Health Organization, the United Nations, the World Customs Union and the US Food and Drug Authority.
He pointed out that according to the statistics of the World Health Organization, 1% of medicines in the developed world are counterfeit, while the percentage reaches 10% in some African and East Asian countries, while the percentage of fraudulent and counterfeit medicines reaches 33% of the volume of medicines in some developing countries.
He pointed out that 50% of the medicines sold online are counterfeit, explaining that counterfeiting operations target medicines of high value, or those with a high consumption rate, and popular and sought-after medicines.
Al Amiri continued: “The Ministry of Health and Community Protection is focusing with the health authorities in the country, in continuous cooperation and coordination with the Federal Customs Authority and local customs departments, on combating drug fraud, through electronic programs and smart electronic applications concerned with this, with the use of modern technologies to distinguish between the original drug and the fake and counterfeit drug during A few minutes, which enhances the UAE’s global position in attracting innovative and similar medicines and their rapid registration, while supporting the import and re-export programs that characterize the country.”
The Ministry’s Assistant Undersecretary for the Health Regulation Sector pointed out that international companies take the UAE as their global and regional headquarters, with the total number of scientific offices reaching 91 offices representing international drug companies, in addition to launching their logistical services from the UAE, through which 41 countries in the world are supported. Medicines and medical supplies. He pointed out that the UAE’s distinction in combating counterfeit and counterfeit medicine constitutes a protection for society, and a protection for countries that are supplied with medicines through the Emirates.
Al-Amiri indicated that the Ministry of Health and Community Protection issues hundreds of circulars and warnings annually about falsified medicines and medical preparations, which are monitored through the Supreme National Committee for Pharmacovigilance headed by the Ministry with all health authorities with jurisdiction at the state level, and the Ministry of Health is directly linked to the Uppsala Center for Drug Monitoring. The Ministry of Health monitors websites that market some types of medicines, pointing out that the UAE bears its responsibility towards the world in combating drug fraud.
For his part, Director of Regulation and Rehabilitation at the World Health Organization Rogerio Jasper said: “The value of counterfeit medicines in low-income countries is estimated at about $30.5 billion, while countries that have achieved advanced efficiency and continuous self-development have achieved 28% for the year 2020.” He pointed out that the organization launched in 2013 the drug control and audit program, to improve the quantity, quality and quality of data related to counterfeit and low-quality medicines, and analyze this data with the aim of prevention, monitoring and taking the necessary measures to protect public health.
He added that the organization has a global database of substandard and falsified medicines, according to reports it receives from regulatory authorities in member states, which aims to provide technical and practical support to protect society, and analyze this data. The Medicinal Product Trace Program aims to prevent counterfeit medicines from entering regulated supply baskets, to improve drug safety and protect patients.
Dr. Magdy Abdo, Regional Director of Health Legislation and Drug Registration for Servier, said: “The conference is of great importance as it discusses addressing the manufacture of counterfeit medicine, smuggling it to global markets, and selling it through websites, social media platforms and smart phone applications. Today, participants in the conference are discussing how to protect patients. From counterfeit and fraudulent medicine as it threatens to cause serious complications to patients.”
He pointed out that the sessions are discussing the classification of fraudulent medicine as an organized crime, as it deliberately targets a segment of patients, and is considered the first crime against patients in low-income countries. He pointed out that counterfeit pharmaceutical products cause a loss of confidence in medicines produced by licensed companies, in health care service providers, and in health systems.
The activities of the Fourth International Emirates Conference on Combating Counterfeiting in Medical Products, organized by the Ministry of Health and Community Protection, kicked off today at the Expo 2020 Dubai Exhibition Center. Fraudulent to protect the health of communities from drug fraud.
The conference, which concludes tomorrow, will be attended by 10 international organizations and Western, Arab and Gulf bodies concerned with combating drug fraud, including the United Nations, the World Health Organization, organizations specialized in the drug industry and combating drug counterfeiting, and experts from different countries of the world. The participants in the conference will discuss the growing phenomenon of manufacturing counterfeit medicines and selling them through websites all over the world.
Specialists from the US Food and Drug Administration, the British Medicines Authority, the European Medicines Authority, the United Nations, the World Customs Organization and the Council of Europe to combat cybercrime spoke at the conference.
The Ministry’s Assistant Undersecretary for the Health Regulation Sector and Conference Chair, Dr. Amin Hussein Al-Amiri, stressed that the UAE government pays special attention to the pharmaceutical sector, and there is great interest from the competent authorities in the various health institutions in the country. He pointed out that the UAE is among the best countries in the region in combating drug fraud in coordination and cooperation with relevant international and global organizations, led by the World Health Organization, the United Nations, the World Customs Union and the US Food and Drug Authority.
He pointed out that according to the statistics of the World Health Organization, 1% of medicines in the developed world are counterfeit, while the percentage reaches 10% in some African and East Asian countries, while the percentage of fraudulent and counterfeit medicines reaches 33% of the volume of medicines in some developing countries.
He pointed out that 50% of the medicines sold online are counterfeit, explaining that counterfeiting operations target medicines of high value, or those with a high consumption rate, and popular and sought-after medicines.
Al Amiri continued: “The Ministry of Health and Community Protection is focusing with the health authorities in the country, in continuous cooperation and coordination with the Federal Customs Authority and local customs departments, on combating drug fraud, through electronic programs and smart electronic applications concerned with this, with the use of modern technologies to distinguish between the original drug and the fake and counterfeit drug during A few minutes, which enhances the UAE’s global position in attracting innovative and similar medicines and their rapid registration, while supporting the import and re-export programs that characterize the country.”
The Ministry’s Assistant Undersecretary for the Health Regulation Sector pointed out that international companies take the UAE as their global and regional headquarters, with the total number of scientific offices reaching 91 offices representing international drug companies, in addition to launching their logistical services from the UAE, through which 41 countries in the world are supported. Medicines and medical supplies. He pointed out that the UAE’s distinction in combating counterfeit and counterfeit medicine constitutes a protection for society, and a protection for countries that are supplied with medicines through the Emirates.
Al-Amiri indicated that the Ministry of Health and Community Protection issues hundreds of circulars and warnings annually about falsified medicines and medical preparations, which are monitored through the Supreme National Committee for Pharmacovigilance headed by the Ministry with all health authorities with jurisdiction at the state level, and the Ministry of Health is directly linked to the Uppsala Center for Drug Monitoring. The Ministry of Health monitors websites that market some types of medicines, pointing out that the UAE bears its responsibility towards the world in combating drug fraud.
For his part, Director of Regulation and Rehabilitation at the World Health Organization Rogerio Jasper said: “The value of counterfeit medicines in low-income countries is estimated at about $30.5 billion, while countries that have achieved advanced efficiency and continuous self-development have achieved 28% for the year 2020.” He pointed out that the organization launched in 2013 the drug control and audit program, to improve the quantity, quality and quality of data related to counterfeit and low-quality medicines, and analyze this data with the aim of prevention, monitoring and taking the necessary measures to protect public health.
He added that the organization has a global database of substandard and falsified medicines, according to reports it receives from regulatory authorities in member states, which aims to provide technical and practical support to protect society, and analyze this data. The Medicinal Product Trace Program aims to prevent counterfeit medicines from entering regulated supply baskets, to improve drug safety and protect patients.
Dr. Magdy Abdo, Regional Director of Health Legislation and Drug Registration for Servier, said: “The conference is of great importance as it discusses addressing the manufacture of counterfeit medicine, smuggling it to global markets, and selling it through websites, social media platforms and smart phone applications. Today, participants in the conference are discussing how to protect patients. From counterfeit and fraudulent medicine as it threatens to cause serious complications to patients.”
He pointed out that the sessions are discussing the classification of fraudulent medicine as an organized crime, as it deliberately targets a segment of patients, and is considered the first crime against patients in low-income countries. He pointed out that counterfeit pharmaceutical products cause a loss of confidence in medicines produced by licensed companies, in health care service providers, and in health systems.
The activities of the Fourth International Emirates Conference on Combating Counterfeiting in Medical Products, organized by the Ministry of Health and Community Protection, kicked off today at the Expo 2020 Dubai Exhibition Center. Fraudulent to protect the health of communities from drug fraud.
The conference, which concludes tomorrow, will be attended by 10 international organizations and Western, Arab and Gulf bodies concerned with combating drug fraud, including the United Nations, the World Health Organization, organizations specialized in the drug industry and combating drug counterfeiting, and experts from different countries of the world. The participants in the conference will discuss the growing phenomenon of manufacturing counterfeit medicines and selling them through websites all over the world.
Specialists from the US Food and Drug Administration, the British Medicines Authority, the European Medicines Authority, the United Nations, the World Customs Organization and the Council of Europe to combat cybercrime spoke at the conference.
The Ministry’s Assistant Undersecretary for the Health Regulation Sector and Conference Chair, Dr. Amin Hussein Al-Amiri, stressed that the UAE government pays special attention to the pharmaceutical sector, and there is great interest from the competent authorities in the various health institutions in the country. He pointed out that the UAE is among the best countries in the region in combating drug fraud in coordination and cooperation with relevant international and global organizations, led by the World Health Organization, the United Nations, the World Customs Union and the US Food and Drug Authority.
He pointed out that according to the statistics of the World Health Organization, 1% of medicines in the developed world are counterfeit, while the percentage reaches 10% in some African and East Asian countries, while the percentage of fraudulent and counterfeit medicines reaches 33% of the volume of medicines in some developing countries.
He pointed out that 50% of the medicines sold online are counterfeit, explaining that counterfeiting operations target medicines of high value, or those with a high consumption rate, and popular and sought-after medicines.
Al Amiri continued: “The Ministry of Health and Community Protection is focusing with the health authorities in the country, in continuous cooperation and coordination with the Federal Customs Authority and local customs departments, on combating drug fraud, through electronic programs and smart electronic applications concerned with this, with the use of modern technologies to distinguish between the original drug and the fake and counterfeit drug during A few minutes, which enhances the UAE’s global position in attracting innovative and similar medicines and their rapid registration, while supporting the import and re-export programs that characterize the country.”
The Ministry’s Assistant Undersecretary for the Health Regulation Sector pointed out that international companies take the UAE as their global and regional headquarters, with the total number of scientific offices reaching 91 offices representing international drug companies, in addition to launching their logistical services from the UAE, through which 41 countries in the world are supported. Medicines and medical supplies. He pointed out that the UAE’s distinction in combating counterfeit and counterfeit medicine constitutes a protection for society, and a protection for countries that are supplied with medicines through the Emirates.
Al-Amiri indicated that the Ministry of Health and Community Protection issues hundreds of circulars and warnings annually about falsified medicines and medical preparations, which are monitored through the Supreme National Committee for Pharmacovigilance headed by the Ministry with all health authorities with jurisdiction at the state level, and the Ministry of Health is directly linked to the Uppsala Center for Drug Monitoring. The Ministry of Health monitors websites that market some types of medicines, pointing out that the UAE bears its responsibility towards the world in combating drug fraud.
For his part, Director of Regulation and Rehabilitation at the World Health Organization Rogerio Jasper said: “The value of counterfeit medicines in low-income countries is estimated at about $30.5 billion, while countries that have achieved advanced efficiency and continuous self-development have achieved 28% for the year 2020.” He pointed out that the organization launched in 2013 the drug control and audit program, to improve the quantity, quality and quality of data related to counterfeit and low-quality medicines, and analyze this data with the aim of prevention, monitoring and taking the necessary measures to protect public health.
He added that the organization has a global database of substandard and falsified medicines, according to reports it receives from regulatory authorities in member states, which aims to provide technical and practical support to protect society, and analyze this data. The Medicinal Product Trace Program aims to prevent counterfeit medicines from entering regulated supply baskets, to improve drug safety and protect patients.
Dr. Magdy Abdo, Regional Director of Health Legislation and Drug Registration for Servier, said: “The conference is of great importance as it discusses addressing the manufacture of counterfeit medicine, smuggling it to global markets, and selling it through websites, social media platforms and smart phone applications. Today, participants in the conference are discussing how to protect patients. From counterfeit and fraudulent medicine as it threatens to cause serious complications to patients.”
He pointed out that the sessions are discussing the classification of fraudulent medicine as an organized crime, as it deliberately targets a segment of patients, and is considered the first crime against patients in low-income countries. He pointed out that counterfeit pharmaceutical products cause a loss of confidence in medicines produced by licensed companies, in health care service providers, and in health systems.